@dev-doshi Hey Dev, I think this is a very insightful response! To answer your questions, starting with stakeholders risk tolerance I think the amount of uncertainty that stakeholders are willing to accept is dependent on the organization. Large corporations likely…   Read more»

@dev-doshi You make great points in avoidance, as it is not always the dominant or most appropriate strategy to use in the development of medical devices. If we truly avoided all risk, we would never build implantable devices, never develop…   Read more»

@dev-doshi completely agree. I work in a medical device manufacturer. And for us, the name of the game isn’t pure avoidance, but risk mitigation. By the time we start planning out the manufacture of a device, we’re looking more at…   Read more»

@dev-doshi Very valid input. However, to comment on one of your suggestions, in order to make the ‘nooks and crannies’ check easier, the team should be aligned and clear on what their roles and expectations are. The PM needs to…   Read more»

Great post, @dev-doshi! I really like how you connected the mission statement, design process, and marketing together. I completely agree that marketing shouldn’t be treated as a separate function. At the end of the day, both design and marketing are…   Read more»

Thank you for the detailed and thoughtful response, @dev-doshi! I completely agree with your point that stricter scientific review should be part of the marketing process, especially in a field like medical devices, where misinformation can directly affect patient outcomes….   Read more»